Join
Live feed
·
INSIDERFilingvia Quantisnow
Legend Biotech Corporation logo

Director Heyman Tomas J. was granted 20,986 units of Ordinary Shares, increasing direct ownership by 64% to 53,720 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
LEGN· Legend Biotech Corporation
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LEGN (Legend Biotech Corporation) and more on Quantisnow.